Get the Stockscreener App
3.02
5.03%
-0.16
Heartsciences Inc stock is traded at $3.02, with a volume of 128.84K.
It is down -5.03% in the last 24 hours and down -20.32% over the past month.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
See More
Previous Close:
$3.18
Open:
$3.18
24h Volume:
128.84K
Relative Volume:
0.37
Market Cap:
$14.63M
Revenue:
$8,700
Net Income/Loss:
$-8.49M
P/E Ratio:
-0.6125
EPS:
-4.9303
Net Cash Flow:
$-7.39M
1W Performance:
-5.03%
1M Performance:
-20.32%
6M Performance:
+46.60%
1Y Performance:
-11.31%
1-Day Range:
$3.00
$3.27
1-Week Range:
$2.89
$3.42
52-Week Range:
$1.63
$5.25
Heartsciences Inc Stock (HSCS) Company Profile
Name
Heartsciences Inc
Sector
Industry
Phone
682-237-7781
Address
550 RESERVE ST, SUITE 360, SOUTHLAKE
Compare HSCS vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HSCS
Heartsciences Inc
|
3.02 | 14.63M | 8,700 | -8.49M | -7.39M | -4.9303 |
ABT
Abbott Laboratories
|
104.89 | 181.50B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.75 | 121.20B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
294.66 | 113.02B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.39 | 64.33B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.60 | 49.92B | 6.30B | 1.07B | 1.09B | 1.8406 |
Heartsciences Inc Stock (HSCS) Latest News
Thermo Fisher to Report Q3 Earnings: What's in the Cards? - Zacks Investment Research
HeartSciences Secures FDA 510(k) Clearance for MyoVista wavECG Device (K260005) - Kalkine Media
HeartSciences Secures FDA 510(k) Clearance for MyoVista wavECG Device Under K260005 - Kalkine Media
HeartSciences Submits Supplemental Proxy Materials Detailing Fortitude Merger and New Legal Appointment - Kalkine Media
Form S-3 HEARTSCIENCES INC. For: 25 September By Investing.com - Investing.com Canada
HeartSciences Warrant (HSCSW) Climbs 25.17% to $0.05 in Sub-Penny TradingATR Stop - dars.gov.et
HeartSciences (NASDAQ: HSCS) asks investors to back a shift into crypto mining - Stock Titan
HeartSciences Widens Q1 Loss to $3.2 Million as wavECG Device Is Shelved - Minichart
HSCS 8-K FilingsHeartSciences Inc. SEC 8-K - Stock Titan
HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update - The Manila Times
HeartSciences posts $3.2M loss, cash down to $29.9K - Stock Titan
HSCS Q1'26 Earnings: EPS estimate is (0.72) USD - TradingView
HSCS Q1'26 Earnings: revenue estimate is 0 USD - TradingView
HeartSciences (HSCSW) Latest: Shows Minimal Net Change at $0.04 in Latest Trading; Chart Watch: the Near-Term Reference Band Stretches From $0.04 to $0.04 in the Latest SessionPositive Gamma - vinanet.vn
HeartSciences (HSCSW) Latest: Shows Minimal Net Change at $0.04 in Latest Trading; Chart Watch: the Near-Term Reference Band Stretches From $0.04 to $0.04 in the Latest SessionSMA Signal - dars.gov.et
HeartSciences(HSCS) Stock Options Chain | Quotes & News - Moomoo
Fortitude invests USD 1M in HeartSciences - Medical Buyer
Fortitude Mining Invests in HeartSciences Ahead Planned Merger - TipRanks
HeartSciences: Fortitude buys $1.0M of stock, merger on track as Fortitude posts $20.9M revenue, $8.5M adj. EBITDA - TradingView
Fortitude Mining reports $21M Q2 revenue and plots public listing via reverse merger - Crypto Briefing
Fortitude Provides Second Quarter 2026 Financial and Operating Highlights - marketscreener.com
Press Release: Fortitude Provides Second Quarter 2026 Financial and Operating Highlights - Moomoo
Fortitude Provides Second Quarter 2026 Financial and Operating Highlights - businesswire.com
HeartSciences and Fortitude Mining Sign Definitive All-Stock Merger Agreement - Minichart
Form 8K HeartSciences Inc For: 19 August By Investing.com - Investing.com Nigeria
Fortitude Now Holds About 9.4% of HeartSciences' Outstanding Shares of Common Stock >HSCS - Moomoo
Fortitude Investment Strengthens HeartSciences Ahead Planned Merger - TipRanks
BRIEF-Fortitude Invests $1.0 Million In Heartsciences At A 22% Premium With No Adjustment To The Merger Consideration - Bitget
[8-K/A] HeartSciences Inc. Amends Material Event Report - Stock Titan
Fortitude Invests $1.0 Million In Heartsciences At A 22% Premium With No Adjustment To The Merger Consideration - TradingView
HeartSciences Announces $1 Million Fortitude Investment at 22% Premium Ahead of Proposed Merger - Quiver Quantitative
HeartSciences (HSCS) Earnings Snapshot: EPS Falls Short of Its Estimate; Market Response: Shares Fall 3.62% in the Latest ReadingFinal Results - vinanet.vn
HeartSciences (HSCS) Earnings Snapshot: EPS Falls Short of Its Estimate; Market Response: Shares Fall 3.62% in the Latest ReadingRevenue Growth Report - Vinanet
HeartSciences (HSCS) Earnings Snapshot: EPS Falls Short of Its Estimate; Market Response: Shares Fall 3.62% in the Latest ReadingEstimate Dispersion - dars.gov.et
Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration - The Manila Times
HeartSciences sells 411,522 shares to Fortitude in $1 million private placement at $2.43 each - Bitget
DCG stake sets up voting control of HeartSciences (HSCS) - Stock Titan
Digital Currency Group Discloses Investment at HeartSciences with 9.4% Stake - TradingView
Form 8K HeartSciences Inc For: 18 August By Investing.com - Investing.com South Africa
Form 8K HeartSciences Inc For: 18 August By Investing.com - Investing.com Nigeria
HeartSciences Completes Private Placement to Support Merger - TipRanks
Form 8K HeartSciences Inc For: 18 August By Investing.com - Investing.com Canada
Form 8K HeartSciences Inc For: 18 August By Investing.com - Investing.com India
HeartSciences (HSCS) Holds Steady at $2.06 as Shares FlatlineETF Premium Discount - vinanet.vn
HeartSciences Inc (HSCS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
HeartSciences Inc. (HSCS) Holds at $2.02 After 1.00% Gain as Key Levels Remain in FocusSentiment Shift - dars.gov.et
HSCS Q2 2026 Earnings: Wider-Than-Expected Loss Highlights Pre-Revenue AI-ECG BurnRevenue Inflection Point - vinanet.vn
HeartSciences Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
HeartSciences Inc. Revenue Breakdown – BOATS:HSCSW - TradingView
Fortitude Completes Acquisition of 12.5 MW Prosser, Nebraska Facility - Business Wire
Heartsciences Inc Stock (HSCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.19%
34.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):